AUTOIMMUNE BRAIN PANEL

Serial Number 98526858
Registration 7734072
700

Registration Progress

Application Filed
Apr 30, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered
Mar 18, 2025

Trademark Image

AUTOIMMUNE BRAIN PANEL

Basic Information

Serial Number
98526858
Registration Number
7734072
Filing Date
April 30, 2024
Registration Date
March 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
042 044

Rights Holder

Moleculera Biosciences, Inc.

03
Address
755 Research Parkway, Suite 410
Oklahoma City, OK 73104

Ownership History

Moleculera Biosciences, Inc.

Original Applicant
03
Oklahoma City, OK

Moleculera Biosciences, Inc.

Original Registrant
03
Oklahoma City, OK

Legal Representation

Attorney
David M. Sullivan

USPTO Deadlines

Next Deadline
2067 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Mar 18, 2025 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 18, 2025 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Feb 21, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 21, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 21, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 21, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 21, 2025 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Feb 17, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 19, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 19, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 19, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 16, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 16, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 16, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 16, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 30, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 30, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Clinical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Laboratory testing of materials; Medical and scientific research information in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Providing a website featuring educational information in the field of clinical research
First Use Anywhere: Mar 5, 2024
First Use in Commerce: Mar 5, 2024
Class 044
Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels
First Use Anywhere: Mar 5, 2024
First Use in Commerce: Mar 5, 2024

Additional Information

Pseudo Mark
AUTO IMMUNE BRAIN PANEL

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PANEL"